seed
Stage
3
Investors
About
Neuronostics develops EEG-based software that uses machine learning to derive objective neurodiagnostic biomarkers for epilepsy and other brain disorders, with the goal of speeding and improving diagnostic and treatment decisions.
Explore Neuronostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.